Urologix, Inc. (ULGX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2013 | 1.39 Million USD | -28.43% |
| 2012 | 1.95 Million USD | 34.81% |
| 2011 | 1.44 Million USD | 28.48% |
| 2010 | 1.12 Million USD | -24.77% |
| 2009 | 1.49 Million USD | 6.47% |
| 2008 | 1.4 Million USD | -13.89% |
| 2007 | 1.63 Million USD | -32.51% |
| 2006 | 2.42 Million USD | -8.09% |
| 2005 | 2.63 Million USD | 51.21% |
| 2004 | 1.74 Million USD | -18.75% |
| 2003 | 2.14 Million USD | -25.89% |
| 2002 | 2.89 Million USD | 19.35% |
| 2001 | 2.42 Million USD | 10.03% |
| 2000 | 2.2 Million USD | 51.51% |
| 1999 | 1.45 Million USD | -39.42% |
| 1998 | 2.4 Million USD | -44.19% |
| 1997 | 4.3 Million USD | 104.76% |
| 1996 | 2.1 Million USD | 425.0% |
| 1995 | 400 Thousand USD | -20.0% |
| 1994 | 500 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2014 Q3 | 1.31 Million USD | -0.3% |
| 2014 Q2 | 1.32 Million USD | 0.68% |
| 2014 Q1 | 1.31 Million USD | -5.94% |
| 2013 Q3 | 1.32 Million USD | -2.65% |
| 2013 Q1 | 2.01 Million USD | 3.33% |
| 2013 Q2 | 1.35 Million USD | -32.72% |
| 2013 Q4 | 1.39 Million USD | 5.75% |
| 2013 FY | 1.39 Million USD | -28.43% |
| 2012 Q2 | 2.03 Million USD | -1.31% |
| 2012 Q3 | 2.46 Million USD | 21.05% |
| 2012 FY | 1.95 Million USD | 34.81% |
| 2012 Q1 | 2.06 Million USD | 42.27% |
| 2012 Q4 | 1.95 Million USD | -20.68% |
| 2011 FY | 1.44 Million USD | 28.48% |
| 2011 Q1 | 1.64 Million USD | 46.23% |
| 2011 Q3 | 1.7 Million USD | -12.01% |
| 2011 Q4 | 1.44 Million USD | -14.82% |
| 2011 Q2 | 1.93 Million USD | 17.23% |
| 2010 Q3 | 1.58 Million USD | -3.54% |
| 2010 Q4 | 1.12 Million USD | -28.76% |
| 2010 FY | 1.12 Million USD | -24.77% |
| 2010 Q2 | 1.64 Million USD | 3.67% |
| 2010 Q1 | 1.58 Million USD | 5.61% |
| 2009 FY | 1.49 Million USD | 6.47% |
| 2009 Q1 | 1.28 Million USD | -8.96% |
| 2009 Q2 | 1.26 Million USD | -1.17% |
| 2009 Q3 | 1.39 Million USD | 10.51% |
| 2009 Q4 | 1.49 Million USD | 7.08% |
| 2008 Q4 | 1.4 Million USD | -9.4% |
| 2008 FY | 1.4 Million USD | -13.89% |
| 2008 Q3 | 1.55 Million USD | -7.72% |
| 2008 Q2 | 1.68 Million USD | 3.44% |
| 2008 Q1 | 1.62 Million USD | -0.43% |
| 2007 Q2 | 2.12 Million USD | -7.36% |
| 2007 Q4 | 1.63 Million USD | -14.72% |
| 2007 FY | 1.63 Million USD | -32.51% |
| 2007 Q1 | 2.29 Million USD | -5.16% |
| 2007 Q3 | 1.91 Million USD | -9.92% |
| 2006 Q3 | 2.87 Million USD | 1.06% |
| 2006 Q2 | 2.84 Million USD | -1.8% |
| 2006 Q1 | 2.89 Million USD | 9.87% |
| 2006 FY | 2.42 Million USD | -8.09% |
| 2006 Q4 | 2.42 Million USD | -15.7% |
| 2005 Q4 | 2.63 Million USD | -20.35% |
| 2005 FY | 2.63 Million USD | 51.21% |
| 2005 Q3 | 3.3 Million USD | 22.39% |
| 2005 Q1 | 2.05 Million USD | 17.85% |
| 2005 Q2 | 2.7 Million USD | 31.61% |
| 2004 Q3 | 2.12 Million USD | -12.23% |
| 2004 FY | 1.74 Million USD | -18.75% |
| 2004 Q1 | 2.2 Million USD | 2.89% |
| 2004 Q4 | 1.74 Million USD | -18.02% |
| 2004 Q2 | 2.42 Million USD | 9.75% |
| 2003 Q1 | 2.68 Million USD | -7.29% |
| 2003 Q3 | 2.4 Million USD | -13.79% |
| 2003 Q2 | 2.78 Million USD | 3.8% |
| 2003 FY | 2.14 Million USD | -25.89% |
| 2003 Q4 | 2.14 Million USD | -10.67% |
| 2002 Q1 | 3.2 Million USD | 32.01% |
| 2002 Q4 | 2.89 Million USD | -38.05% |
| 2002 Q3 | 4.67 Million USD | -4.79% |
| 2002 Q2 | 4.9 Million USD | 53.28% |
| 2002 FY | 2.89 Million USD | 19.35% |
| 2001 Q2 | 3.18 Million USD | 23.57% |
| 2001 Q1 | 2.58 Million USD | 17.11% |
| 2001 Q3 | 3.28 Million USD | 2.98% |
| 2001 Q4 | 2.42 Million USD | -26.17% |
| 2001 FY | 2.42 Million USD | 10.03% |
| 2000 Q4 | 2.2 Million USD | -5.57% |
| 2000 Q3 | 2.33 Million USD | 5.42% |
| 2000 Q2 | 2.21 Million USD | 66.14% |
| 2000 Q1 | 1.33 Million USD | -8.39% |
| 2000 FY | 2.2 Million USD | 51.51% |
| 1999 Q4 | 1.45 Million USD | 158.29% |
| 1999 FY | 1.45 Million USD | -39.42% |
| 1999 Q1 | 2 Million USD | -16.67% |
| 1999 Q2 | 1.2 Million USD | -40.0% |
| 1999 Q3 | 562.93 Thousand USD | -53.09% |
| 1998 Q1 | 3 Million USD | -30.23% |
| 1998 Q2 | 2.9 Million USD | -3.33% |
| 1998 Q3 | 3 Million USD | 3.45% |
| 1998 FY | 2.4 Million USD | -44.19% |
| 1998 Q4 | 2.4 Million USD | -20.0% |
| 1997 Q3 | 3.9 Million USD | 2.63% |
| 1997 Q2 | 3.8 Million USD | 65.22% |
| 1997 FY | 4.3 Million USD | 104.76% |
| 1997 Q4 | 4.3 Million USD | 10.26% |
| 1997 Q1 | 2.3 Million USD | 9.52% |
| 1996 Q3 | 1.7 Million USD | 41.67% |
| 1996 Q1 | 700 Thousand USD | 75.0% |
| 1996 Q2 | 1.2 Million USD | 71.43% |
| 1996 Q4 | 2.1 Million USD | 23.53% |
| 1996 FY | 2.1 Million USD | 425.0% |
| 1995 Q4 | 400 Thousand USD | 0.0% |
| 1995 FY | 400 Thousand USD | -20.0% |
| 1994 Q4 | 500 Thousand USD | 0.0% |
| 1994 FY | 500 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Avitar, Inc. | 225.15 Thousand USD | -520.459% |
| BioElectronics Corporation | 41.05 Thousand USD | -3303.001% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | -81.00 USD | 1724791.358% |
| Medical Supply International USA, Inc. | 29.3 Thousand USD | -4667.105% |
| Polarean Imaging plc | 2.21 Million USD | 37.035% |
| AVITA Medical, Inc. | 3.12 Million USD | 55.245% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 136.22 Million USD | 98.974% |
| Zecotek Photonics Inc. | 94.9 Thousand USD | -1372.076% |
| QHSLab, Inc. | 25.18 Thousand USD | -5447.834% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 136.22 Million USD | 98.974% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 11.15 Million USD | 87.481% |
| Escalon Medical Corp. | 1.61 Million USD | 13.398% |
| Aurora Spine Corporation | 3.54 Million USD | 60.583% |
| BrainsWay Ltd. | 3.71 Million USD | 62.416% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 14.36 Million USD | 90.277% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 414.75 Million USD | 99.663% |
| Kelyniam Global, Inc. | 46.22 Thousand USD | -2922.043% |
| REMSleep Holdings, Inc. | 99.14 Thousand USD | -1309.019% |
| CYduct Diagnostics, Inc. | 12.19 Thousand USD | -11360.213% |
| Nanomix Corporation | - USD | -Infinity% |
| Theraclion SA | 3.05 Million EUR | 54.267% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 125.67 Thousand USD | -1011.562% |
| Positron Corporation | 1.25 Million USD | -11.15% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 68.51 Thousand USD | -1938.91% |
| Lombard Medical, Inc. | 6.87 Million USD | 79.686% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 157.55 Million USD | 99.113% |
| Vycor Medical, Inc. | 234.14 Thousand USD | -496.639% |
| Heart Tronics, Inc. | 163.85 Thousand USD | -752.578% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 128.99 Thousand USD | -982.954% |
| SANUWAVE Health, Inc. | 2.95 Million USD | 52.66% |
| VMS Rehab Systems, Inc. | 1.33 USD | -105037493.985% |
| Guided Therapeutics, Inc. | 632 Thousand USD | -121.044% |
| Ingen Technologies, Inc. | 85.59 Thousand USD | -1532.124% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 313.4 Thousand USD | -345.743% |
| Rapid Therapeutic Science Laboratories, Inc. | 175.04 Thousand USD | -698.071% |
| Nexeon MedSystems Inc. | 2.2 Million USD | 36.689% |
| SS Innovations International, Inc. | 6.32 Million USD | 77.921% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | 99.942% |
| NIOX Group Plc | 6.11 Million USD | 77.137% |
| Fuse Medical, Inc. | 9.11 Million USD | 84.682% |
| Broncus Holding Corporation | 4.7 Million USD | 70.325% |
| Brain Scientific Inc. | 149.55 Thousand USD | -834.086% |
| Pressure BioSciences, Inc. | 304.9 Thousand USD | -358.169% |
| Health Logic Interactive Inc. | -4511.80 USD | 31063.252% |